The Added Value of Neural Mobilization Techniques to Proprioceptive Neuromuscular Facilitation in Patients With Adhesive Capsulitis: Randomized Controlled Trial.

Physiother Res IntSep 18, 2026
Clinical ResearchPhysical Medicine & Rehabilitation

Mohammed Moustafa Aldosouki Hegazy, Saud M Alrawaili, Tamer Emam El Negamy et al.

✦ AI-curated · Sources linked

In 30 seconds

This randomized controlled trial evaluated the effectiveness of combining neural mobilization techniques (NMTs) with proprioceptive neuromuscular facilitation (PNF) in 56 patients with adhesive capsulitis. The experimental group showed significant improvements in pain intensity, functional disability, and passive range of motion, with shoulder abduction improving by 14.08° (p < 0.001), suggesting potential clinical relevance.

Key findings

  • The experimental group had a VAS pain score improvement of 0.88 (p < 0.001).
  • Functional disability measured by SPADI improved by 5.69 points (p = 0.008).
  • Shoulder abduction increased by 14.08° (p < 0.001), indicating potential clinical significance.
  • Changes in pain and disability did not reach the minimal clinically important difference (MCID) thresholds.

Why it matters

Understanding the effectiveness of combined therapeutic techniques can guide clinicians in optimizing treatment strategies for adhesive capsulitis, particularly in enhancing shoulder mobility.

Source

PubMed · PMID 42750164

Published in Physiother Res Int. This summary was written by xxcode from the publication's abstract and metadata. It is not peer reviewed and is not a substitute for the original article. For clinical decisions, review the original publication.

ShareTelegramLinkedIn

AI-generated summaries may contain errors or omissions. Verify clinically important information with the original publication.

More in Physical Medicine & Rehabilitation

Clinical ResearchHematology

Ponatinib-Blinatumomab or Imatinib-Chemotherapy for Adult Ph-Positive ALL.

This multicenter, phase 3 randomized trial compared frontline ponatinib plus blinatumomab with imatinib plus chemotherapy in adults with Philadelphia-positive acute lymphoblastic leukemia.

N Engl J MedOct 15, 2026Read summary
Clinical ResearchHematology

Efficacy and safety of mitapivat in patients with sickle cell disease (RISE UP): a phase 3, double-blind, global, randomised, placebo-controlled trial.

RISE UP was a phase 3, double-blind, global, randomised, placebo-controlled trial conducted at 69 sites in 15 countries. It evaluated twice-daily mitapivat in patients older than 16 years with sickle cell disease…

LancetOct 24, 2026Read summary
Clinical ResearchRheumatology

Ianalumab for the Treatment of Patients with Sjögren's Disease.

Two 52-week, double-blind, randomized, placebo-controlled phase III trials evaluated monthly or less frequent ianalumab in patients with active Sjögren's disease.

N Engl J MedOct 22, 2026Read summary

Want this personalized?

Stop searching the literature. Choose what you follow and xxcode will build your personalized medical digest.

  • Your specialties
  • Your filters and thresholds
  • Clinical Research + Case Reports, tuned separately
  • Automatic weekly delivery
  • Audio and text
Create my personalized digestSee plans

Prefer listening? Personalized audio digests are available with Pro.

Stay updated for free

Get the 3 most interesting publications in one specialty each week.

Weekly email. Unsubscribe anytime.